DRREDDY Q1 FY27 results at a glance
DR. REDDY S LABORATORIES Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹8,071 cr |
|---|
| Revenue YoY | -5.6% |
|---|
| Operating profit | ₹303 cr |
|---|
| Operating margin | 3.8% |
|---|
| Net profit | ₹444 cr |
|---|
| Net profit YoY | -68.7% |
|---|
| Net profit QoQ | +100.8% |
|---|
| Net margin | 5.5% |
|---|
| Basic EPS | ₹5.32 |
|---|
| TTM revenue | ₹33,119 cr |
|---|
| TTM net profit | ₹3,311 cr |
|---|
| TTM net margin | 10.0% |
|---|
DRREDDY Q1 FY27 results: what the numbers say
DR. REDDY S LABORATORIES (DRREDDY) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹8,071 cr and a net profit of ₹444 cr, translating into earnings per share of ₹5.32.
Compared with the same quarter a year earlier, revenue declined by -5.6% and net profit declined sharply by -68.7%. Profit trailing revenue growth suggests costs, interest or tax absorbed part of the topline gain.
Operating profit for the quarter stood at ₹303 cr, an operating margin of 3.8% versus 19.7% a year ago — a contraction of 16.0 percentage points.
DRREDDY quarter-wise results table
Revenue
₹8,071 cr
-5.6% YoY
Net profit
₹444 cr
-68.7% YoY
Operating profit
₹303 cr
-82.0% YoY
DR. REDDY S LABORATORIES (DRREDDY) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹8,071 cr | ₹303 cr | ₹444 cr | 3.8% | 5.5% | ₹5.32 | -68.7% | +100.8% |
| Q4 FY262026-03-31 | ₹7,516 cr | ₹82.9 cr | ₹221 cr | 1.1% | 2.9% | ₹2.65 | — | -81.7% |
| Q3 FY262025-12-31 | ₹8,727 cr | ₹1,433 cr | ₹1,210 cr | 16.4% | 13.9% | ₹14.53 | — | -15.8% |
| Q2 FY262025-09-30 | ₹8,805 cr | ₹1,787 cr | ₹1,437 cr | 20.3% | 16.3% | — | — | +1.4% |
| Q1 FY262025-06-30 | ₹8,545 cr | ₹1,684 cr | ₹1,418 cr | 19.7% | 16.6% | ₹17.04 | — | — |
| TTM (last 4 quarters) | ₹33,119 cr | ₹3,606 cr | ₹3,311 cr | 10.9% | 10.0% | — | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
DRREDDY quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
DR. REDDY S LABORATORIES quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹8,071 cr | ₹7,516 cr | ₹8,727 cr | ₹8,805 cr | ₹8,545 cr |
|---|
| Total expenses | ₹7,767 cr | ₹7,433 cr | ₹7,294 cr | ₹7,018 cr | ₹6,861 cr |
|---|
| Gross profit | ₹3,754 cr | ₹4,304 cr | ₹4,681 cr | ₹4,814 cr | ₹4,863 cr |
|---|
| Operating profit (EBIT) | ₹303 cr | ₹82.9 cr | ₹1,433 cr | ₹1,787 cr | ₹1,684 cr |
|---|
| Operating margin | 3.8% | 1.1% | 16.4% | 20.3% | 19.7% |
|---|
| Interest cost | ₹126 cr | ₹106 cr | ₹94.4 cr | ₹90.7 cr | ₹83 cr |
|---|
| Profit before tax | ₹553 cr | ₹200 cr | ₹1,543 cr | ₹1,835 cr | ₹1,905 cr |
|---|
| Tax expense | ₹118 cr | -₹21.6 cr | ₹353 cr | ₹408 cr | ₹495 cr |
|---|
| Effective tax rate | 21.3% | -10.8% | 22.9% | 22.2% | 26.0% |
|---|
| Net profit (PAT) | ₹444 cr | ₹221 cr | ₹1,210 cr | ₹1,437 cr | ₹1,418 cr |
|---|
| Net profit margin | 5.5% | 2.9% | 13.9% | 16.3% | 16.6% |
|---|
| Basic EPS | ₹5.32 | ₹2.65 | ₹14.53 | — | ₹17.04 |
|---|
| Diluted EPS | ₹5.32 | ₹2.65 | ₹14.52 | — | ₹17.02 |
|---|
DRREDDY results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | -5.6% | — | — | — | — |
|---|
| Revenue QoQ | +7.4% | -13.9% | -0.9% | +3.0% | — |
|---|
| Operating profit YoY | -82.0% | — | — | — | — |
|---|
| Operating profit QoQ | +265.9% | -94.2% | -19.8% | +6.1% | — |
|---|
| Net profit YoY | -68.7% | — | — | — | — |
|---|
| Net profit QoQ | +100.8% | -81.7% | -15.8% | +1.4% | — |
|---|
| EPS YoY | -68.8% | — | — | — | — |
|---|
| EPS QoQ | +100.8% | -81.8% | — | — | — |
|---|
DRREDDY annual results history
Full-year performance for DR. REDDY S LABORATORIES, useful for reading each quarter in context.
DR. REDDY S LABORATORIES annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹33,593 cr | ₹32,554 cr | ₹27,916 cr | ₹24,588 cr |
|---|
| Total expenses | ₹28,581 cr | ₹25,352 cr | ₹21,386 cr | ₹18,683 cr |
|---|
| Gross profit | ₹17,726 cr | ₹19,043 cr | ₹16,361 cr | ₹13,934 cr |
|---|
| Operating profit (EBIT) | ₹5,012 cr | ₹7,201 cr | ₹6,531 cr | ₹5,905 cr |
|---|
| Operating margin | 14.9% | 22.1% | 23.4% | 24.0% |
|---|
| Interest cost | ₹374 cr | ₹283 cr | ₹171 cr | ₹143 cr |
|---|
| Profit before tax | ₹5,482 cr | ₹7,678 cr | ₹7,187 cr | ₹6,037 cr |
|---|
| Tax expense | ₹1,235 cr | ₹1,954 cr | ₹1,619 cr | ₹1,530 cr |
|---|
| Effective tax rate | 22.5% | 25.4% | 22.5% | 25.3% |
|---|
| Net profit (PAT) | ₹4,285 cr | ₹5,654 cr | ₹5,568 cr | ₹4,507 cr |
|---|
| Net profit margin | 12.8% | 17.4% | 19.9% | 18.3% |
|---|
| Basic EPS | ₹51.48 | ₹67.88 | ₹67.04 | ₹54.28 |
|---|
| Diluted EPS | ₹51.42 | ₹67.78 | ₹66.92 | ₹54.17 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹8,071 cr against ₹8,545 cr in Q1 FY26, and ₹7,516 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +7.4%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹7,767 cr, or 96.2% of revenue, with operating profit declined -82.0% year on year.
Margins, tax and profitability
Net profit of ₹444 cr works out to a net margin of 5.5% compared with 16.6% in the year-ago quarter. Margin pressure of this kind usually reflects higher input costs, pricing competition, or a heavier interest and depreciation load.
Below the operating line, DR. REDDY S LABORATORIES reported profit before tax of ₹553 cr, a tax charge of ₹118 cr (effective rate 21.3%), interest cost of ₹126 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹221 cr in Q4 FY26 to ₹444 cr in Q1 FY27, a change of +100.8%.
Trailing twelve months and annual context
Across the trailing four quarters DR. REDDY S LABORATORIES has generated revenue of ₹33,119 cr and net profit of ₹3,311 cr, a trailing net margin of 10.0%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹33,593 cr with net profit of ₹4,285 cr and EPS of ₹51.48, versus the prior year where revenue grew +3.2% and profit declined -24.2%.
What to watch in the next DRREDDY quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.
DR. REDDY S LABORATORIES has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
DRREDDY results coverage
No results report published for DRREDDY yet — our desk covers each quarter within minutes of the filing.
DRREDDY quarterly results FAQs
What were DR. REDDY S LABORATORIES (DRREDDY) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), DR. REDDY S LABORATORIES reported revenue of ₹8,071 cr and net profit of ₹444 cr, a change of -68.7% year on year on -5.6% revenue growth. EPS stood at ₹5.32.
What is DRREDDY profit margin in Q1 FY27?
DR. REDDY S LABORATORIES posted a net profit margin of 5.5% and an operating margin of 3.8% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹33,119 cr and net profit ₹3,311 cr.
Did DRREDDY results beat the previous quarter?
DR. REDDY S LABORATORIES net profit changed +100.8% quarter on quarter, from ₹221 cr in Q4 FY26 to ₹444 cr in Q1 FY27.
When are DR. REDDY S LABORATORIES (DRREDDY) quarterly results?
DR. REDDY S LABORATORIES has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see DRREDDY latest quarterly results?
Results coverage for DRREDDY will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the DRREDDY stock page.
What is DR. REDDY S LABORATORIES annual revenue and profit?
For FY26, DR. REDDY S LABORATORIES reported full-year revenue of ₹33,593 cr and net profit of ₹4,285 cr, with EPS of ₹51.48.
How many quarterly results has DRREDDY declared recently?
Past results dates for DRREDDY will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 11 Sept 2026. For information only, not investment advice.
